GATEX
Price
$47.41
Change
+$0.15 (+0.32%)
Updated
Jun 26 closing price
Net Assets
6.74B
GCPNX
Price
$20.07
Change
+$0.05 (+0.25%)
Updated
Jun 26 closing price
Net Assets
263.58M
Interact to see
Advertisement

GATEX vs GCPNX

Header iconGATEX vs GCPNX Comparison
Open Charts GATEX vs GCPNXBanner chart's image
Gateway A
Price$47.41
Change+$0.15 (+0.32%)
VolumeN/A
Net Assets6.74B
Gateway Equity Call Premium N
Price$20.07
Change+$0.05 (+0.25%)
VolumeN/A
Net Assets263.58M
GATEX vs GCPNX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GATEX vs. GCPNX commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GATEX is a Buy and GCPNX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GATEX has more cash in the bank: 6.74B vs. GCPNX (264M). GCPNX pays higher dividends than GATEX: GCPNX (0.75) vs GATEX (0.36). GATEX was incepted earlier than GCPNX: GATEX (48 years) vs GCPNX (8 years). GCPNX (1.05) is less costly to investors than GATEX (0.98). GCPNX is a more actively managed with annual turnover of: 19.00 vs. GATEX (12.00). GATEX has a lower initial minimum investment than GCPNX: GATEX (2500) vs GCPNX (1000000). GATEX (8.32) and GCPNX (7.95) have marching annual gain over last year. GCPNX return over 5 years is better than : 72.64 vs. GATEX (45.30).
GATEXGCPNXGATEX / GCPNX
Total Expense Ratio0.940.63149%
Annual Report Gross Expense Ratio0.981.0593%
Fund Existence48 years8 years-
Gain YTD2.1571.174184%
Front Load6%N/A-
Min. Initial Investment250010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets6.74B264M2,552%
Annual Yield % from dividends0.360.7549%
Returns for 1 year8.327.95105%
Returns for 3 years32.9940.5781%
Returns for 5 years45.3072.6462%
Returns for 10 years65.81N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JNGLX65.960.14
+0.21%
Janus Henderson Global Life Sciences D
FDCGX80.59N/A
N/A
Fidelity Advisor Consumer Staples C
GMICX22.40N/A
N/A
GMO International Equity II
BRWUX26.14N/A
N/A
MFS Blended Research Growth Eq R4
LSCGX21.10N/A
N/A
Loomis Sayles Global Growth C